ArticleClinical and translational medicine2025
DNA damage response pathway is a promising therapeutic target for extrachromosomal DNA-positive tumours.
Congcong Tian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it